141 related articles for article (PubMed ID: 26441251)
1. Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites.
Boonpawa R; Moradi N; Spenkelink A; Rietjens IM; Punt A
Biochem Pharmacol; 2015 Dec; 98(4):690-702. PubMed ID: 26441251
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats.
Boonpawa R; Spenkelink A; Rietjens IM; Punt A
Biochem Pharmacol; 2014 May; 89(2):287-99. PubMed ID: 24561179
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolites of dietary flavonoids after combination meal consumption with onion and tofu in humans.
Nakamura T; Murota K; Kumamoto S; Misumi K; Bando N; Ikushiro S; Takahashi N; Sekido K; Kato Y; Terao J
Mol Nutr Food Res; 2014 Feb; 58(2):310-7. PubMed ID: 24039174
[TBL] [Abstract][Full Text] [Related]
4. UHPLC-(ESI)QTOF MS/MS profiling of quercetin metabolites in human plasma postconsumption of applesauce enriched with apple peel and onion.
Lee J; Ebeler SE; Zweigenbaum JA; Mitchell AE
J Agric Food Chem; 2012 Aug; 60(34):8510-20. PubMed ID: 22867437
[TBL] [Abstract][Full Text] [Related]
5. Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems.
van der Woude H; Boersma MG; Vervoort J; Rietjens IM
Chem Res Toxicol; 2004 Nov; 17(11):1520-30. PubMed ID: 15540950
[TBL] [Abstract][Full Text] [Related]
6. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin.
Day AJ; Mellon F; Barron D; Sarrazin G; Morgan MR; Williamson G
Free Radic Res; 2001 Dec; 35(6):941-52. PubMed ID: 11811545
[TBL] [Abstract][Full Text] [Related]
7. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
[TBL] [Abstract][Full Text] [Related]
8. Plasma metabolites of quercetin and their antioxidant properties.
Morand C; Crespy V; Manach C; Besson C; Demigné C; Rémésy C
Am J Physiol; 1998 Jul; 275(1):R212-9. PubMed ID: 9688981
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and modeling of quercetin and metabolites.
Chen X; Yin OQ; Zuo Z; Chow MS
Pharm Res; 2005 Jun; 22(6):892-901. PubMed ID: 15948033
[TBL] [Abstract][Full Text] [Related]
10. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
11. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
[TBL] [Abstract][Full Text] [Related]
12. Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers.
Chalet C; Rubbens J; Tack J; Duchateau GS; Augustijns P
J Pharm Pharmacol; 2018 Aug; 70(8):1002-1008. PubMed ID: 29761870
[TBL] [Abstract][Full Text] [Related]
13. Comparing the metabolism of quercetin in rats, mice and gerbils.
Yeh SL; Lin YC; Lin YL; Li CC; Chuang CH
Eur J Nutr; 2016 Feb; 55(1):413-22. PubMed ID: 25691233
[TBL] [Abstract][Full Text] [Related]
14. [HPLC-MS analysis of quercetin and its metabolites in portal vein after intragastrical administration of quercetin in rats].
An D; Wu S; Wei J; Yang J
Wei Sheng Yan Jiu; 2009 Jul; 38(4):417-9. PubMed ID: 19689070
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the bioavailability of quercetin and catechin in rats.
Manach C; Texier O; Morand C; Crespy V; Régérat F; Demigné C; Rémésy C
Free Radic Biol Med; 1999 Dec; 27(11-12):1259-66. PubMed ID: 10641719
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans.
Boonpawa R; Spenkelink A; Punt A; Rietjens IMCM
Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218440
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism.
Silberberg M; Morand C; Manach C; Scalbert A; Remesy C
Life Sci; 2005 Nov; 77(25):3156-67. PubMed ID: 15979103
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Interindividual Human Variation in Bioactivation and DNA Adduct Formation of Estragole in Liver Predicted by Physiologically Based Kinetic/Dynamic and Monte Carlo Modeling.
Punt A; Paini A; Spenkelink A; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2016 Apr; 29(4):659-68. PubMed ID: 26952143
[TBL] [Abstract][Full Text] [Related]
19. Conjugated metabolites represent the major circulating forms of Abelmoschus manihot in vivo and show an altered pharmacokinetic profile in renal pathology.
Guo J; Du L; Shang E; Li T; Liu Y; Qian D; Tang Y; Duan J
Pharm Biol; 2016; 54(4):595-603. PubMed ID: 26186460
[TBL] [Abstract][Full Text] [Related]
20. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
